MSK screening in the diabetic foot is vital in ulceration prevention and healing. This presentation will explore its importance by detailing the development of the offloading pathway that is compliant with both NICE NG19 and IWGDF guidelines. Attendees will learn about MSK changes in the diabetic foot. Audit outcomes of ulceration prevention, ulceration healing times and re-ulceration rates will be evaluated. Subsequent pathway improvements, including the development of the reablement programme, and re-audit will also be discussed.